President Trump was taken aback when Treasury chief Steven Mnuchin said the U.S. asked China's trade delegation to reschedule a farm tour.Politicsread more
As China marks the 70th anniversary of its founding on Oct. 1, CNBC takes a look at the rise of the Asian giant through the years — and projections of where it's headed.China Economyread more
The tax cut came as Indian Prime Minister Narendra Modi's government attempts to spur the country's slowing economy.Asia Economyread more
Lawmakers in Congress on Monday pressed for full disclosure of a whistleblower's complaint about President Donald Trump as Democratic calls for impeachment intensified over...Politicsread more
Stocks have been grinding sideways, but technical analysts say once they breakout, the move to the upside could be powerful.Market Insiderread more
The brewer also issued an additional 189,354,000 shares. Budweiser APAC's IPO is now expected to raise about US$5 billion.China Marketsread more
Rising home prices and conservative borrowing have today's homeowners sitting on a record amount of potential cash. Today's mortgage holders saw their home equity increase by...Real Estateread more
Shareholders are accusing Tesla of improperly valuing the SolarCity deal, providing flawed analysis and misleading investors.Technologyread more
The FAA says each country's regulator will decide when the Boeing 737 Max can return to the skies as the grounding of Boeing's best seller, edges toward its eighth month.Airlinesread more
U.S. Treasury Secretary Steven Mnuchin said Monday that the two country's negotiators had made some progress in easing their trade tensions in last week's deputy-level...World Politicsread more
Stocks were barely changed. American Express gained, but Netflix was a notable laggard.Marketsread more
U.S. stock futures were pointing to a lower open Wednesday a day after the Dow Jones Industrial Average gave up nearly half of Monday's 270-point bounce. The 623-point Dow plunge Friday, put August deeper into the red, risking the second monthly drop in an otherwise strong 2019. The culprit for the recent decline in stocks has been falling bond yields. Investors have been piling into the perceived safety of fixed-income on concerns about a global economic slowdown and the U.S.-China trade war.
With bond prices soaring in their reverse relationship with yields, the inversion of the 10-year Treasury yield deepened as it fell further below that of the 2-year on Wednesday morning. That inversion, the worst since 2007, has briefly happened a number of times in recent weeks. But this time it persisted since flip-flopping again Tuesday. Such a move has preceded every recession in the U.S. over the past 50 years, though the economic downturn on average tends to lag by up to two years.
The 30-year Treasury yield went below 2% again, hitting a new record low Wednesday morning after dropping below the S&P 500′s stock dividend yield on Tuesday for the first time since 2009. Bespoke Investment Group examined data going back four decades. Other than the financial crisis, the only other time when a similar stock-bond inversion came close to happening was in July 2016, right after the Brexit vote.
The British pound dropped against the U.S. dollar Wednesday morning after U.K. Prime Minister Boris Johnson said he would schedule the formal reopening of parliament for Oct. 14 — a highly controversial move that would restrict lawmakers' time to act before the Brexit deadline two weeks later, and increase the chances of the U.K. leaving the European trading bloc with no deal. Johnson is seeking to strike a renewed departure agreement with the EU.
Purdue Pharma and its owners, the Sackler family, are offering to settle more than 2,000 lawsuits against the company for $10 billion to $12 billion. The potential deal was part of confidential conversations and discussed by Purdue's lawyers at a meeting in Cleveland last week on Aug. 20, two people familiar with the mediation told NBC News. Privately held Purdue Pharma makes the opioid painkiller OxyContin. On Monday, an Oklahoma judge ruled against Johnson & Johnson in the state's opioid lawsuit, ordering the company pay a $572 million fine. J&J plans to appeal.